Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 2
1956 1
1958 2
1963 2
1965 2
1967 2
1968 1
1969 4
1970 4
1971 6
1972 2
1973 1
1975 3
1976 5
1977 2
1978 2
1980 1
1981 5
1982 3
1983 2
1984 2
1985 3
1986 3
1987 6
1988 13
1989 14
1990 9
1991 7
1992 8
1993 7
1994 3
1995 15
1996 22
1997 15
1998 20
1999 12
2000 9
2001 12
2002 5
2003 5
2004 6
2005 10
2006 19
2007 16
2008 22
2009 30
2010 32
2011 52
2012 77
2013 77
2014 66
2015 77
2016 83
2017 77
2018 110
2019 114
2020 164
2021 201
2022 173
2023 167
2024 48

Text availability

Article attribute

Article type

Publication date

Search Results

1,680 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse).
Stein Gold LF, Bagel J, Tyring SK, Hong HC, Pavlovsky L, Vender R, Pinter A, Reich A, Drogaris L, Wu T, Patel M, Soliman AM, Photowala H, Stakias V, Richter S, Papp KA. Stein Gold LF, et al. Among authors: soliman am. Br J Dermatol. 2023 Oct 25;189(5):540-552. doi: 10.1093/bjd/ljad252. Br J Dermatol. 2023. PMID: 37488811 Clinical Trial.
2020: A Crash Course in Digital Health.
Soliman AM, Zoghbi WA. Soliman AM, et al. Methodist Debakey Cardiovasc J. 2020 Oct-Dec;16(4):261-262. doi: 10.14797/mdcj-16-4-261. Methodist Debakey Cardiovasc J. 2020. PMID: 33500753 Free PMC article. No abstract available.
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial.
Kristensen LE, Keiserman M, Papp K, McCasland L, White D, Lu W, Wang Z, Soliman AM, Eldred A, Barcomb L, Behrens F. Kristensen LE, et al. Among authors: soliman am. Ann Rheum Dis. 2022 Feb;81(2):225-231. doi: 10.1136/annrheumdis-2021-221019. Epub 2021 Dec 15. Ann Rheum Dis. 2022. PMID: 34911706 Free PMC article. Clinical Trial.
Negotiating a pandemic accord: a promising start.
Matsoso P, Driece R, da Silva Nunes T, Soliman A, Taguchi K, Tangcharoensathien V. Matsoso P, et al. Among authors: soliman a. BMJ. 2023 Mar 2;380:506. doi: 10.1136/bmj.p506. BMJ. 2023. PMID: 36863729 No abstract available.
Treatment for vestibular schwannoma: Systematic review and single arm meta-analysis.
Thai NLB, Mai NY, Vuong NL, Tin NM, Karam D, Refaey MA, Shahin KM, Soliman AL, Al Khudari R, Thuan TM, Sabbah GM, El-Qushayri AE, Karimzadeh S, Hirayama K, Huy NT. Thai NLB, et al. Among authors: soliman al. Am J Otolaryngol. 2022 Mar-Apr;43(2):103337. doi: 10.1016/j.amjoto.2021.103337. Epub 2021 Dec 20. Am J Otolaryngol. 2022. PMID: 34973662 Review.
The Evaluation of Lymphadenopathy in a Resource-Limited Setting.
Ali M, Elhatw A, Hegazy M, Albeyoumi H, Sakr N, Deyab AM, Soliman AY, Said E, Samir Elbehwashy A, Nassar M, Alfishawy M. Ali M, et al. Among authors: soliman ay. Cureus. 2022 Oct 24;14(10):e30623. doi: 10.7759/cureus.30623. eCollection 2022 Oct. Cureus. 2022. PMID: 36426328 Free PMC article. Review.
A Framework for Evaluating Synthetic Electronic Health Records.
Budu E, Soliman A, Etminani K, Rögnvaldsson T. Budu E, et al. Among authors: soliman a. Stud Health Technol Inform. 2023 May 18;302:378-379. doi: 10.3233/SHTI230149. Stud Health Technol Inform. 2023. PMID: 37203694 Review.
Manifestations of HbSE sickle cell disease: a systematic review.
Khamees I, Ata F, Choudry H, Soliman AT, De Sanctis V, Yassin MA. Khamees I, et al. Among authors: soliman at. J Transl Med. 2021 Jun 16;19(1):262. doi: 10.1186/s12967-021-02931-1. J Transl Med. 2021. PMID: 34134694 Free PMC article. Review.
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up.
Papp KA, Blauvelt A, Puig L, Ohtsuki M, Beissert S, Gooderham M, Amin AZ, Liu J, Wu T, Azam T, Stakias V, Espaillat R, Sinvhal R, Soliman AM, Pang Y, Chen MM, Lebwohl MG. Papp KA, et al. Among authors: soliman am. J Am Acad Dermatol. 2023 Dec;89(6):1149-1158. doi: 10.1016/j.jaad.2023.07.1024. Epub 2023 Aug 6. J Am Acad Dermatol. 2023. PMID: 37553030 Free article. Clinical Trial.
1,680 results